Practice Management News

In this fourth of six articles by lawyers from Epstein Becker & Green and the analysts from Provident Healthcare Partners LLC, Gary Herschman, Esq., Abe M’Bodj and Anjana D. Patel delve into the hot sector of gastroenterology, explaining how private equity investment is growing in this field.

Physicians taking part in a recent survey said 20.6% of overall medical care and about 22% of prescription medications given in the United States are unnecessary.

More than 2 years since then-President Barack Obama signed the Medicare Access and CHIP Reauthorization Act — or MACRA — into law, many medical professionals appear to need assistance on applying the 2015 law to their practices.

In response to the devastation caused by Hurricane Harvey in Texas and Louisiana, HHS Secretary Tom Price, MD, declared a public health emergency in both states following President Donald J. Trump’s disaster declarations.

Benjamin Franklin famously said that an investment in knowledge pays the best dividends. Building a well-trained team can improve efficiency and increase the bottom line. Here are six ways to build your practice “brain bank.”

Want to engage with more Twitter users during the next medical conference? Try including links in your tweets.

In separate letters to CMS Administrator Seema Verma, MPH, the AMA and ACP submitted comments and recommendations to simplify and improve the proposed rule to update the Quality Payment Program that was established by the Medicare Access and CHIP Reauthorization Act.

Earlier this year, AMA swore in family physician David O. Barbe, MD, as its 172nd president. Previously, he had served in various capacities on AMA’s board and its committees.

The long-term effects of the FDA Reauthorization Act of 2017 — signed into law by President Donald J. Trump on Monday — may include savings in drug-related Medicare expenses due to increased competition encouraged by the FDA by fast-tracking generic competitor approvals, according to an expert.

President Donald J. Trump recently signed the FDA Reauthorization Act of 2017 into law.